- Home
- ZIM vs CNTA Comparison
ZIM vs CNTA Comparison
Compare ZIM & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZIM
- CNTA
- Stock Information
- Founded
- ZIM 1945
- CNTA 2020
- Country
- ZIM Israel
- CNTA United Kingdom
- Employees
- ZIM N/A
- CNTA N/A
- Industry
- ZIM Marine Transportation
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- ZIM Consumer Discretionary
- CNTA Health Care
- Exchange
- ZIM Nasdaq
- CNTA Nasdaq
- Market Cap
- ZIM 2.0B
- CNTA 2.3B
- IPO Year
- ZIM 2021
- CNTA 2021
- Fundamental
- Price
- ZIM $13.32
- CNTA $15.79
- Analyst Decision
- ZIM Sell
- CNTA Strong Buy
- Analyst Count
- ZIM 4
- CNTA 11
- Target Price
- ZIM $13.23
- CNTA $30.60
- AVG Volume (30 Days)
- ZIM 6.5M
- CNTA 1.0M
- Earning Date
- ZIM 08-20-2025
- CNTA 08-12-2025
- Dividend Yield
- ZIM 53.56%
- CNTA N/A
- EPS Growth
- ZIM N/A
- CNTA N/A
- EPS
- ZIM 16.63
- CNTA N/A
- Revenue
- ZIM $8,575,100,000.00
- CNTA $15,000,000.00
- Revenue This Year
- ZIM N/A
- CNTA N/A
- Revenue Next Year
- ZIM N/A
- CNTA N/A
- P/E Ratio
- ZIM $0.80
- CNTA N/A
- Revenue Growth
- ZIM 43.57
- CNTA 118.88
- 52 Week Low
- ZIM $11.04
- CNTA $9.60
- 52 Week High
- ZIM $30.15
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- ZIM 30.22
- CNTA 42.04
- Support Level
- ZIM $13.39
- CNTA $15.01
- Resistance Level
- ZIM $14.00
- CNTA $17.68
- Average True Range (ATR)
- ZIM 0.59
- CNTA 0.80
- MACD
- ZIM -0.20
- CNTA -0.24
- Stochastic Oscillator
- ZIM 0.00
- CNTA 24.92
About ZIM ZIM Integrated Shipping Services Ltd.
ZIM Integrated Shipping Services Ltd is an asset-light container liner shipping company. It offers tailored services, including land transportation and logistical services, specialized shipping solutions, including the transportation of out-of-gauge cargo, refrigerated cargo, and dangerous and hazardous cargo. Its services include Cargo Services, Digital Services, Schedules, and Shipping Trades and Lines. Geographically, it derives a majority of its revenue from the Pacific trade region.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.